Joy MS - Search Results

1

Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease.

Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ. Joy MS, et al. Pharmacotherapy. 2007 May;27(5):734-44. doi: 10.1592/phco.27.5.734. Pharmacotherapy. 2007. PMID: 17461709

2

Calcineurin inhibitor-induced nephrotoxicity and renal expression of P-glycoprotein.

Joy MS, Nickeleit V, Hogan SL, Thompson BD, Finn WF. Joy MS, et al. Pharmacotherapy. 2005 Jun;25(6):779-89. doi: 10.1592/phco.2005.25.6.779. Pharmacotherapy. 2005. PMID: 15927895

3

Lanthanum carbonate.

Joy MS, Kshirsagar A, Candiani C, Brooks T, Hudson JQ. Joy MS, et al. Ann Pharmacother. 2006 Feb;40(2):234-40. doi: 10.1345/aph.1G224. Epub 2006 Jan 31. Ann Pharmacother. 2006. PMID: 16449551 Review.

4

Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.

Joy MS, Dornbrook-Lavender KA, Chin H, Hogan SL, Denu-Ciocca C. Joy MS, et al. Ann Pharmacother. 2008 Jan;42(1):9-15. doi: 10.1345/aph.1K407. Epub 2007 Nov 13. Ann Pharmacother. 2008. PMID: 18000162 Clinical Trial.

5

Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.

Joy MS, Hilliard T, Hu Y, Hogan SL, Dooley MA, Falk RJ, Smith PC. Joy MS, et al. Pharmacotherapy. 2009 Jan;29(1):7-16. doi: 10.1592/phco.29.1.7. Pharmacotherapy. 2009. PMID: 19113793 Free PMC article. Clinical Trial.

6

Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis.

Joy MS, Hilliard T, Hu Y, Hogan SL, Wang J, Falk RJ, Smith PC. Joy MS, et al. Ann Pharmacother. 2009 Jun;43(6):1020-7. doi: 10.1345/aph.1L699. Epub 2009 Jun 2. Ann Pharmacother. 2009. PMID: 19491317 Free PMC article. Clinical Trial.

7

Predialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care.

Hansen RA, Chin H, Blalock S, Joy MS. Hansen RA, et al. Among authors: joy ms. Res Social Adm Pharm. 2009 Jun;5(2):143-53. doi: 10.1016/j.sapharm.2008.06.004. Epub 2009 Jan 31. Res Social Adm Pharm. 2009. PMID: 19524862 Free PMC article. Clinical Trial.

8

In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases.

Joy MS, Frye RF, Nolin TD, Roberts BV, La MK, Wang J, Brouwer KL, Dooley MA, Falk RJ. Joy MS, et al. Pharmacotherapy. 2014 Feb;34(2):114-22. doi: 10.1002/phar.1347. Epub 2013 Sep 6. Pharmacotherapy. 2014. PMID: 24038489 Free PMC article. Clinical Trial.

9

Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.

Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA. Dornbrook-Lavender KA, et al. Among authors: joy ms. Pharmacotherapy. 2005 Mar;25(3):335-44. doi: 10.1592/phco.25.3.335.61599. Pharmacotherapy. 2005. PMID: 15843280 Clinical Trial.

10

Cutaneous and systemic manifestations of drug-induced vasculitis.

ten Holder SM, Joy MS, Falk RJ. ten Holder SM, et al. Among authors: joy ms. Ann Pharmacother. 2002 Jan;36(1):130-47. doi: 10.1345/aph.1A124. Ann Pharmacother. 2002. PMID: 11816242 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters